GB989826A - Process of preparing a polypeptide from a mammalian liver extract fraction and therapeutic composition containing same - Google Patents
Process of preparing a polypeptide from a mammalian liver extract fraction and therapeutic composition containing sameInfo
- Publication number
- GB989826A GB989826A GB5516/63A GB551663A GB989826A GB 989826 A GB989826 A GB 989826A GB 5516/63 A GB5516/63 A GB 5516/63A GB 551663 A GB551663 A GB 551663A GB 989826 A GB989826 A GB 989826A
- Authority
- GB
- United Kingdom
- Prior art keywords
- polypeptide
- phenylalanine
- enzyme
- acid
- product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 229940040511 liver extract Drugs 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract 6
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 abstract 3
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 abstract 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 abstract 2
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 abstract 2
- 239000005695 Ammonium acetate Substances 0.000 abstract 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 2
- 108090000790 Enzymes Proteins 0.000 abstract 2
- 102000004190 Enzymes Human genes 0.000 abstract 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
- 108091005804 Peptidases Proteins 0.000 abstract 2
- 102000035195 Peptidases Human genes 0.000 abstract 2
- 229940043376 ammonium acetate Drugs 0.000 abstract 2
- 235000019257 ammonium acetate Nutrition 0.000 abstract 2
- 230000003266 anti-allergic effect Effects 0.000 abstract 2
- 230000001387 anti-histamine Effects 0.000 abstract 2
- 239000000872 buffer Substances 0.000 abstract 2
- 239000003729 cation exchange resin Substances 0.000 abstract 2
- 238000010828 elution Methods 0.000 abstract 2
- 230000006862 enzymatic digestion Effects 0.000 abstract 2
- 229940088598 enzyme Drugs 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 abstract 1
- 239000004475 Arginine Substances 0.000 abstract 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 abstract 1
- 239000004471 Glycine Substances 0.000 abstract 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 abstract 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 abstract 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 abstract 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 abstract 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 abstract 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 abstract 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 abstract 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
- 239000004472 Lysine Substances 0.000 abstract 1
- 108090000526 Papain Proteins 0.000 abstract 1
- 239000004793 Polystyrene Substances 0.000 abstract 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 abstract 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 abstract 1
- 239000004473 Threonine Substances 0.000 abstract 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 235000004279 alanine Nutrition 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 abstract 1
- 229940024606 amino acid Drugs 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 1
- 235000003704 aspartic acid Nutrition 0.000 abstract 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 abstract 1
- 230000029087 digestion Effects 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 238000005194 fractionation Methods 0.000 abstract 1
- 235000013922 glutamic acid Nutrition 0.000 abstract 1
- 239000004220 glutamic acid Substances 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 abstract 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 abstract 1
- 229960000310 isoleucine Drugs 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 229940055729 papain Drugs 0.000 abstract 1
- 235000019834 papain Nutrition 0.000 abstract 1
- 229920002223 polystyrene Polymers 0.000 abstract 1
- 235000013930 proline Nutrition 0.000 abstract 1
- 235000004400 serine Nutrition 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical compound OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 abstract 1
- 235000008521 threonine Nutrition 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 abstract 1
- 239000004474 valine Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/407—Liver; Hepatocytes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR889084A FR1832M (fr) | 1962-02-23 | 1962-02-23 | Médicament anti-allergique, en particulier anti-histaminique, a base d'une fraction d'extrait enzymatique de foie de mammiferes. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB989826A true GB989826A (en) | 1965-04-22 |
Family
ID=9696451
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB5516/63A Expired GB989826A (en) | 1962-02-23 | 1963-02-11 | Process of preparing a polypeptide from a mammalian liver extract fraction and therapeutic composition containing same |
Country Status (3)
| Country | Link |
|---|---|
| BE (1) | BE628373A (enExample) |
| FR (1) | FR1832M (enExample) |
| GB (1) | GB989826A (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2181507A1 (en) * | 1972-04-26 | 1973-12-07 | Boutroux Andre | Animal and vegetable proteolysates prepn - for treatment of undernutrition |
| WO1999043340A1 (en) * | 1998-02-24 | 1999-09-02 | Zetesis S.P.A. | Oral compositions at low dosage of cytotoxic proteins |
-
0
- BE BE628373D patent/BE628373A/xx unknown
-
1962
- 1962-02-23 FR FR889084A patent/FR1832M/fr not_active Expired
-
1963
- 1963-02-11 GB GB5516/63A patent/GB989826A/en not_active Expired
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2181507A1 (en) * | 1972-04-26 | 1973-12-07 | Boutroux Andre | Animal and vegetable proteolysates prepn - for treatment of undernutrition |
| WO1999043340A1 (en) * | 1998-02-24 | 1999-09-02 | Zetesis S.P.A. | Oral compositions at low dosage of cytotoxic proteins |
Also Published As
| Publication number | Publication date |
|---|---|
| BE628373A (enExample) | 1900-01-01 |
| FR1832M (fr) | 1900-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Senior et al. | Studies on the mitochondrial oligomycin-insensitive atpase: I. An improved method of purification and the behavior of the enzyme in solutions of various depolymerizing agents | |
| Azari et al. | A simple and rapid procedure for preparation of large quantities of pure ovotransferrin | |
| Fruton et al. | The mechanism of pepsin action | |
| CN110547458A (zh) | 一种酶解珍珠粉的制备方法 | |
| SATAKE et al. | Studies on Snake Venoms XIV. Hydrolyses of Insulin B Chain and Glucagon by Proteinase c from Agkistrodon halys blomhoffii Venom | |
| GB989826A (en) | Process of preparing a polypeptide from a mammalian liver extract fraction and therapeutic composition containing same | |
| Manchester et al. | Location of 14C in protein from isolated rat diaphragm incubated in vitro with [14C] amino acids and with 14CO2 | |
| Nieuwenhuizen et al. | The isolation and properties of two prephospholipases A2 from porcine pancreas | |
| Delpierre | Studies on african snake venoms—I The proteolytic activities of some african viperidae venoms | |
| CN101643723A (zh) | 一种糜胰蛋白酶的提取方法 | |
| Caldwell et al. | The sites of reaction of wool with formaldehyde | |
| Daly et al. | SYNTHESIS OF PROTEIN IN THE PANCREAS: III. UPTAKE OF GLYCINE-N15BY THE TRYPSINOGEN AND CHYMOTRYPSINOGEN OF MOUSE PANCREAS | |
| Manabe | Purification and Properties of Gitrus natsudaidai Pectinesterase | |
| Mohamed et al. | Some enzymatic activities of Egyptian snake venoms and a scorpion venom | |
| Stehle | The chemistry of the hormones of the posterior lobe of the pituitary gland | |
| Van der Zant et al. | Amino acids and peptides in the protein-free fraction of milk before and after incubation with Streptococcus lactis | |
| Woodley et al. | The presence of pancreatic proteases in particulate preparations of rat intestinal mucosa | |
| Nunokawa | Purification of two acid-proteases of Aspergillus oryzae from takadiastase | |
| GB842806A (en) | Improvements in or relating to the treatment of blood | |
| US2957807A (en) | Process of preparing acth-active concentrates | |
| CN104928337A (zh) | 马面鲀鱼皮锌螯合肽 | |
| Werle et al. | Kallikreins | |
| GB924815A (en) | Improvements in methods of preparation of polypeptides of spasmolytic activity | |
| 吉中禮二 et al. | Studies on pancreatic enzymes in fish. IX. Purification and some properties of two carboxypeptidases B from the catfish pancreas. | |
| Liener | A chromatographic study of acetyltrypsin during autolysis and digestion by carboxypeptidase and aminopeptidase |